Joseph Stringer
Stock Analyst at Needham
(4.59)
# 206
Out of 5,182 analysts
304
Total ratings
50%
Success rate
38.25%
Average return
Main Sectors:
Stocks Rated by Joseph Stringer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Downgrades: Hold | n/a | $40.94 | - | 22 | Mar 31, 2026 | |
| BIOA BioAge Labs | Initiates: Buy | $50 | $17.05 | +193.26% | 1 | Mar 27, 2026 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $103 → $105 | $73.27 | +43.31% | 27 | Mar 25, 2026 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $40 | $34.03 | +17.54% | 25 | Mar 17, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $139 → $130 | $85.70 | +51.69% | 31 | Mar 17, 2026 | |
| VIR Vir Biotechnology | Maintains: Buy | $14 → $18 | $10.37 | +73.58% | 20 | Feb 24, 2026 | |
| GILD Gilead Sciences | Reiterates: Buy | $170 | $130.40 | +30.37% | 11 | Feb 23, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $529 → $510 | $305.54 | +66.92% | 25 | Feb 12, 2026 | |
| PCVX Vaxcyte | Maintains: Buy | $90 → $110 | $59.49 | +84.91% | 18 | Jan 7, 2026 | |
| MRNA Moderna | Reiterates: Hold | n/a | $50.73 | - | 9 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 | $11.70 | +139.32% | 52 | Jun 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $11 | $5.88 | +87.07% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $430.29 | - | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.68 | - | 13 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 | $1.24 | +706.45% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $37 | $21.96 | +68.49% | 6 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $16.46 | +9.36% | 2 | Aug 24, 2021 |
Apellis Pharmaceuticals
Mar 31, 2026
Downgrades: Hold
Price Target: n/a
Current: $40.94
Upside: -
BioAge Labs
Mar 27, 2026
Initiates: Buy
Price Target: $50
Current: $17.05
Upside: +193.26%
Ionis Pharmaceuticals
Mar 25, 2026
Maintains: Buy
Price Target: $103 → $105
Current: $73.27
Upside: +43.31%
Stoke Therapeutics
Mar 17, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $34.03
Upside: +17.54%
Rhythm Pharmaceuticals
Mar 17, 2026
Maintains: Buy
Price Target: $139 → $130
Current: $85.70
Upside: +51.69%
Vir Biotechnology
Feb 24, 2026
Maintains: Buy
Price Target: $14 → $18
Current: $10.37
Upside: +73.58%
Gilead Sciences
Feb 23, 2026
Reiterates: Buy
Price Target: $170
Current: $130.40
Upside: +30.37%
Alnylam Pharmaceuticals
Feb 12, 2026
Maintains: Buy
Price Target: $529 → $510
Current: $305.54
Upside: +66.92%
Vaxcyte
Jan 7, 2026
Maintains: Buy
Price Target: $90 → $110
Current: $59.49
Upside: +84.91%
Moderna
Oct 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $50.73
Upside: -
Jun 6, 2025
Maintains: Buy
Price Target: $28
Current: $11.70
Upside: +139.32%
May 13, 2025
Maintains: Buy
Price Target: $16 → $11
Current: $5.88
Upside: +87.07%
May 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $430.29
Upside: -
Mar 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.68
Upside: -
Mar 4, 2025
Downgrades: Hold
Price Target: $10
Current: $1.24
Upside: +706.45%
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $21.96
Upside: +68.49%
Aug 24, 2021
Maintains: Buy
Price Target: $32 → $18
Current: $16.46
Upside: +9.36%